Cannabis Bioscience International Holdings (CBIH) Gross Profit (2022 - 2026)
Cannabis Bioscience International Holdings' Gross Profit history spans 5 years, with the latest figure at $8160.0 for Q1 2026.
- On a quarterly basis, Gross Profit rose 282.75% to $8160.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $97394.0, a 67.37% decrease, with the full-year FY2025 number at $262916.0, up 29.36% from a year prior.
- Gross Profit hit $8160.0 in Q1 2026 for Cannabis Bioscience International Holdings, down from $42766.0 in the prior quarter.
- Over the last five years, Gross Profit for CBIH hit a ceiling of $170525.0 in Q3 2024 and a floor of -$4465.0 in Q1 2025.
- Historically, Gross Profit has averaged $47583.6 across 5 years, with a median of $36588.5 in 2025.
- Biggest five-year swings in Gross Profit: crashed 118.15% in 2025 and later skyrocketed 282.75% in 2026.
- Tracing CBIH's Gross Profit over 5 years: stood at $75491.0 in 2022, then plummeted by 35.55% to $48656.0 in 2023, then skyrocketed by 36.56% to $66445.0 in 2024, then tumbled by 35.64% to $42766.0 in 2025, then tumbled by 80.92% to $8160.0 in 2026.
- Business Quant data shows Gross Profit for CBIH at $8160.0 in Q1 2026, $42766.0 in Q4 2025, and $16057.0 in Q3 2025.